IM Cannabis (IMCC) Share-based Compensation (QoQ) (2020 - 2025)
IM Cannabis (IMCC) Share-based Compensation (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | IM Cannabis | 537,472.00 | -631,498.17 | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -49.66% |
| Jun 30, 2025 | -48.22% |
| Mar 31, 2025 | 55.77% |
| Dec 31, 2024 | -98.00% |
| Sep 30, 2024 | 178.00% |
| Jun 30, 2024 | 170.93% |
| Mar 31, 2024 | 135.53% |
| Dec 31, 2023 | -145.95% |
| Sep 30, 2023 | 242.62% |
| Jun 30, 2023 | -153.44% |
| Mar 31, 2023 | -46.37% |
| Dec 31, 2022 | -25.87% |
| Sep 30, 2022 | -41.61% |
| Jun 30, 2022 | -35.33% |
| Mar 31, 2022 | -72.72% |
| Dec 31, 2021 | 1,551.50% |
| Sep 30, 2021 | -128.73% |
| Jun 30, 2021 | 124.40% |
| Mar 31, 2021 | -48.13% |
| Dec 31, 2020 | 81.64% |